Chemoinformaics analysis of METHYL 8-(2-OCTYLCYCLOPROPEN-1-YL)OCTANOATE
Molecular Weight | 308.506 | nRot | 15 |
Heavy Atom Molecular Weight | 272.218 | nRig | 1 |
Exact Molecular Weight | 308.272 | nRing | 1 |
Solubility: LogS | -0.486 | nHRing | 0 |
Solubility: LogP | 1.19 | No. of Aliphatic Rings | 1 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
Atoms Count | 58 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 22 | No. of Aromatic Carbocycles | 0 |
nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 36 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 20 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
nHA | 2 | APOL | 59.0085 |
nHD | 0 | BPOL | 38.7195 |
QED | 0.519 |
Synth | 3.642 |
Natural Product Likeliness | 1.762 |
NR-PPAR-gamma | 0.003 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Rejected |
Pgp-inh | 0 |
Pgp-sub | 0.002 |
HIA | 0.004 |
CACO-2 | -4.197 |
MDCK | 0.0000283 |
BBB | 0.995 |
PPB | 0.451805 |
VDSS | 1.186 |
FU | 0.621643 |
CYP1A2-inh | 0.045 |
CYP1A2-sub | 0.625 |
CYP2c19-inh | 0.053 |
CYP2c19-sub | 0.853 |
CYP2c9-inh | 0.019 |
CYP2c9-sub | 0.407 |
CYP2d6-inh | 0.011 |
CYP2d6-sub | 0.163 |
CYP3a4-inh | 0.103 |
CYP3a4-sub | 0.35 |
CL | 7.993 |
T12 | 0.701 |
hERG | 0.014 |
Ames | 0.014 |
ROA | 0.106 |
SkinSen | 0.193 |
Carcinogencity | 0.063 |
EI | 0.992 |
Respiratory | 0.057 |
NR-Aromatase | 0.008 |
Antiviral | Yes |
Prediction | 0.589173 |